FDA Inspection 905257 — Ingenus Pharmaceuticals GmbH

Ingenus Pharmaceuticals GmbH — FEI 3005403232

The FDA completed an inspection of Ingenus Pharmaceuticals GmbH on Nov 4, 2014 in Barbengo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 4, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barbengo (Switzerland)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.